Jolly good imaging firepower to illuminate the intricacies of the brain

The second oldest university in the English-speaking world is getting ready to install two of the newest diagnostic imaging machines on the market. Its hope is to change the game in the study of the brain.

The biomedical campus at Cambridge (Oxford is older) will add a 7T ultrahigh-field MRI scanner and a powerful PET-MRI companion in order advance researchers’ grasp of everything that touches cognition, from dementia to obesity and from pain to addiction.

The school’s website has the story, told in light of a Cambridge professor’s work to understand schizophrenia as it advances (or recedes) in the brains of adolescents: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.